334 related articles for article (PubMed ID: 31477715)
1. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
Pajtler KW; Wei Y; Okonechnikov K; Silva PBG; Vouri M; Zhang L; Brabetz S; Sieber L; Gulley M; Mauermann M; Wedig T; Mack N; Imamura Kawasawa Y; Sharma T; Zuckermann M; Andreiuolo F; Holland E; Maass K; Körkel-Qu H; Liu HK; Sahm F; Capper D; Bunt J; Richards LJ; Jones DTW; Korshunov A; Chavez L; Lichter P; Hoshino M; Pfister SM; Kool M; Li W; Kawauchi D
Nat Commun; 2019 Sep; 10(1):3914. PubMed ID: 31477715
[TBL] [Abstract][Full Text] [Related]
2. Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features.
Andreiuolo F; Varlet P; Tauziède-Espariat A; Jünger ST; Dörner E; Dreschmann V; Kuchelmeister K; Waha A; Haberler C; Slavc I; Corbacioglu S; Riemenschneider MJ; Leipold A; Rüdiger T; Körholz D; Acker T; Russo A; Faber J; Sommer C; Armbrust S; Rose M; Erdlenbruch B; Hans VH; Bernbeck B; Schneider D; Lorenzen J; Ebinger M; Handgretinger R; Neumann M; van Buiren M; Prinz M; Roganovic J; Jakovcevic A; Park SH; Grill J; Puget S; Messing-Jünger M; Reinhard H; Bergmann M; Hattingen E; Pietsch T
Brain Pathol; 2019 Mar; 29(2):205-216. PubMed ID: 30246434
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic characterization with somatic genome editing and gene transfer reveals the diverse oncogenicity of ependymoma fusion genes.
Takadera M; Satomi K; Szulzewsky F; Cimino PJ; Holland EC; Yamamoto T; Ichimura K; Ozawa T
Acta Neuropathol Commun; 2020 Nov; 8(1):203. PubMed ID: 33228790
[TBL] [Abstract][Full Text] [Related]
4. Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis.
Szulzewsky F; Arora S; Hoellerbauer P; King C; Nathan E; Chan M; Cimino PJ; Ozawa T; Kawauchi D; Pajtler KW; Gilbertson RJ; Paddison PJ; Vasioukhin V; Gujral TS; Holland EC
Genes Dev; 2020 Aug; 34(15-16):1051-1064. PubMed ID: 32675324
[TBL] [Abstract][Full Text] [Related]
5. Nuclear condensates of YAP fusion proteins alter transcription to drive ependymoma tumourigenesis.
Hu X; Wu X; Berry K; Zhao C; Xin D; Ogurek S; Liu X; Zhang L; Luo Z; Sakabe M; Trubicka J; Łastowska M; Szulzewsky F; Holland EC; Lee L; Hu M; Xin M; Lu QR
Nat Cell Biol; 2023 Feb; 25(2):323-336. PubMed ID: 36732631
[TBL] [Abstract][Full Text] [Related]
6. C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
Parker M; Mohankumar KM; Punchihewa C; Weinlich R; Dalton JD; Li Y; Lee R; Tatevossian RG; Phoenix TN; Thiruvenkatam R; White E; Tang B; Orisme W; Gupta K; Rusch M; Chen X; Li Y; Nagahawhatte P; Hedlund E; Finkelstein D; Wu G; Shurtleff S; Easton J; Boggs K; Yergeau D; Vadodaria B; Mulder HL; Becksfort J; Gupta P; Huether R; Ma J; Song G; Gajjar A; Merchant T; Boop F; Smith AA; Ding L; Lu C; Ochoa K; Zhao D; Fulton RS; Fulton LL; Mardis ER; Wilson RK; Downing JR; Green DR; Zhang J; Ellison DW; Gilbertson RJ
Nature; 2014 Feb; 506(7489):451-5. PubMed ID: 24553141
[TBL] [Abstract][Full Text] [Related]
7. YAP1/TAZ drives ependymoma-like tumour formation in mice.
Eder N; Roncaroli F; Domart MC; Horswell S; Andreiuolo F; Flynn HR; Lopes AT; Claxton S; Kilday JP; Collinson L; Mao JH; Pietsch T; Thompson B; Snijders AP; Ultanir SK
Nat Commun; 2020 May; 11(1):2380. PubMed ID: 32404936
[TBL] [Abstract][Full Text] [Related]
8. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
[TBL] [Abstract][Full Text] [Related]
9. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
10. C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B Fusion Negative Anaplastic Ependymoma with Lipogenic Differentiation.
Jha S; Mulgulwar PB; Sharma MC; Purkait S; Pattnaik A; Sable MN
Neurol India; 2023; 71(5):1011-1014. PubMed ID: 37929446
[TBL] [Abstract][Full Text] [Related]
11. C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin.
Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Rajeshwari M; Singh M; Suri V; Sarkar C; Sharma MC
J Neurooncol; 2018 May; 138(1):29-39. PubMed ID: 29354850
[TBL] [Abstract][Full Text] [Related]
12. The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis.
Zhou Y; Huang T; Cheng AS; Yu J; Kang W; To KF
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805820
[TBL] [Abstract][Full Text] [Related]
13. A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-κB.
Ozawa T; Arora S; Szulzewsky F; Juric-Sekhar G; Miyajima Y; Bolouri H; Yasui Y; Barber J; Kupp R; Dalton J; Jones TS; Nakada M; Kumabe T; Ellison DW; Gilbertson RJ; Holland EC
Cell Rep; 2018 Jun; 23(13):3787-3797. PubMed ID: 29949764
[TBL] [Abstract][Full Text] [Related]
14. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
[TBL] [Abstract][Full Text] [Related]
15. Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.
Simile MM; Latte G; Demartis MI; Brozzetti S; Calvisi DF; Porcu A; Feo CF; Seddaiu MA; Daino L; Berasain C; Tomasi ML; Avila MA; Feo F; Pascale RM
Oncotarget; 2016 Aug; 7(31):49194-49216. PubMed ID: 27359056
[TBL] [Abstract][Full Text] [Related]
16. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
17. Fluid shear stress activates YAP1 to promote cancer cell motility.
Lee HJ; Diaz MF; Price KM; Ozuna JA; Zhang S; Sevick-Muraca EM; Hagan JP; Wenzel PL
Nat Commun; 2017 Jan; 8():14122. PubMed ID: 28098159
[TBL] [Abstract][Full Text] [Related]
18. TEAD mediates YAP-dependent gene induction and growth control.
Zhao B; Ye X; Yu J; Li L; Li W; Li S; Yu J; Lin JD; Wang CY; Chinnaiyan AM; Lai ZC; Guan KL
Genes Dev; 2008 Jul; 22(14):1962-71. PubMed ID: 18579750
[TBL] [Abstract][Full Text] [Related]
19. ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.
Arabzade A; Zhao Y; Varadharajan S; Chen HC; Jessa S; Rivas B; Stuckert AJ; Solis M; Kardian A; Tlais D; Golbourn BJ; Stanton AJ; Chan YS; Olson C; Karlin KL; Kong K; Kupp R; Hu B; Injac SG; Ngo M; Wang PR; De León LA; Sahm F; Kawauchi D; Pfister SM; Lin CY; Hodges HC; Singh I; Westbrook TF; Chintagumpala MM; Blaney SM; Parsons DW; Pajtler KW; Agnihotri S; Gilbertson RJ; Yi J; Jabado N; Kleinman CL; Bertrand KC; Deneen B; Mack SC
Cancer Discov; 2021 Sep; 11(9):2200-2215. PubMed ID: 33741710
[TBL] [Abstract][Full Text] [Related]
20. YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers.
Stein C; Bardet AF; Roma G; Bergling S; Clay I; Ruchti A; Agarinis C; Schmelzle T; Bouwmeester T; Schübeler D; Bauer A
PLoS Genet; 2015 Aug; 11(8):e1005465. PubMed ID: 26295846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
